Furthermore, the development of more specific SIRT3 activators would be desirable, as so far only less selective compounds with biological activity themselves have been tested, making it difficult to identify the exact role played by SIRT3 in the observed anti-cancer effects of these compounds. This evidence concerns the gene SIRT3 and cancer.